IMRN on Nasdaq
Immuron Ltd
Immuron Ltd is a pharmaceutical preparations company, listed on Nasdaq (IMRN).1
Price unavailable
Last updated Oct 20, 2026.
Overview
- TickerIMRN on Nasdaq1
- IndustryPharmaceutical Preparations1
- HeadquartersC31
- Incorporated inAustralia2
- Business address62 Lygon Street, Level 3, Carlton, Victoria, C3 30532
- Filer categoryNon-accelerated filer2
See how the biggest companies compare on our leaderboards
Australia, Canada, and in new markets. We previously advised that the development of CampETEC product was discontinued.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
No quarterly figures reported.
Every line of the income statement as filed: the last 3 fiscal years, latest first.4
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Revenue from contracts with customers | 7.7M AUD | 7.3M AUD | 4.9M AUD |
| Cost of Goods Sold | -2.7M AUD | -2.5M AUD | -1.6M AUD |
| Gross Profit | 5.0M AUD | 4.8M AUD | 3.3M AUD |
| Grant Income | 1.2M AUD | 1.4M AUD | 3.4M AUD |
| Fair value losses to financial assets | -557.7K AUD | ||
| Net foreign exchange gains/(losses) | -285.1K AUD | 12.2K AUD | -27.6K AUD |
| General and administrative expenses | -4.3M AUD | -4.5M AUD | -4.6M AUD |
| Research and development expenses | -1.9M AUD | -3.6M AUD | -5.4M AUD |
| Selling and marketing expenses | -3.5M AUD | -3.5M AUD | -2.0M AUD |
| Operating loss | -3.9M AUD | -5.3M AUD | -5.8M AUD |
| Finance income | 185.4K AUD | 135.9K AUD | 327.8K AUD |
| Finance expenses | -14.7K AUD | -7.3K AUD | -7.6K AUD |
| Finance costs - net | 170.7K AUD | 128.6K AUD | 320.2K AUD |
| Share of loss from associates | -1.5M AUD | ||
| Loss Before Income Tax | -3.7M AUD | -5.2M AUD | -6.9M AUD |
| Loss for the Period | -3.7M AUD | -5.2M AUD | -6.9M AUD |
| Exchange differences on translation of foreign operations | 16.3K AUD | -1.4K AUD | 2.3K AUD |
| Total Comprehensive Loss for the Period | -3.7M AUD | -5.2M AUD | -6.9M AUD |
| Basic Loss per Share (in cents per share) (in Dollars per share) | -1.24 AUD | -2.26 AUD | -3.04 AUD |
| Diluted Loss per Share (in cents per share) (in Dollars per share) | -1.24 AUD | -2.26 AUD | -3.04 AUD |
No quarter-by-quarter statement was filed.
No quarterly figures reported.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.4
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 9.0M AUD | 2.8M AUD | 11.7M AUD | 17.2M AUD |
| Trade and other receivables | 1.4M AUD | 1.9M AUD | ||
| Inventories | 2.3M AUD | 1.8M AUD | ||
| Other current assets | 258.2K AUD | 3.5M AUD | ||
| Total Current Assets | 13.0M AUD | 10.0M AUD | ||
| Property, plant and equipment | 9.3K AUD | 10.1K AUD | ||
| Right-of-use assets | 183.4K AUD | 103.9K AUD | ||
| Inventories | 666 AUD | |||
| Total Non-Current Assets | 192.7K AUD | 114.6K AUD | ||
| TOTAL ASSETS | 13.2M AUD | 10.1M AUD | 15.5M AUD | |
| Trade and other payables | 1.3M AUD | 1.5M AUD | ||
| Employee benefit obligations | 409.4K AUD | 391.5K AUD | ||
| Other current liabilities | 30.6K AUD | 45.3K AUD | ||
| Total Current Liabilities | 1.8M AUD | 2.0M AUD | ||
| Employee benefit obligations | 42.2K AUD | 22.7K AUD | ||
| Other non-current liabilities | 158.9K AUD | 71.9K AUD | ||
| Total Non-Current Liabilities | 201.1K AUD | 94.6K AUD | ||
| TOTAL LIABILITIES | 2.0M AUD | 2.1M AUD | 2.8M AUD | |
| NET ASSETS | 11.2M AUD | 8.1M AUD | ||
| Issued capital | 95.7M AUD | 88.9M AUD | 88.5M AUD | 88.4M AUD |
| Reserves | 479.5K AUD | 1.6M AUD | ||
| Accumulated losses | -85.0M AUD | -82.4M AUD | ||
| TOTAL EQUITY | 11.2M AUD | 8.1M AUD | 12.7M AUD | 19.6M AUD |
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 9.0M AUD | 2.8M AUD | 11.7M AUD | 17.2M AUD |
| Trade and other receivables | 1.4M AUD | 1.9M AUD | ||
| Inventories | 2.3M AUD | 1.8M AUD | ||
| Other current assets | 258.2K AUD | 3.5M AUD | ||
| Total Current Assets | 13.0M AUD | 10.0M AUD | ||
| Property, plant and equipment | 9.3K AUD | 10.1K AUD | ||
| Right-of-use assets | 183.4K AUD | 103.9K AUD | ||
| Inventories | 666 AUD | |||
| Total Non-Current Assets | 192.7K AUD | 114.6K AUD | ||
| TOTAL ASSETS | 13.2M AUD | 10.1M AUD | 15.5M AUD | |
| Trade and other payables | 1.3M AUD | 1.5M AUD | ||
| Employee benefit obligations | 409.4K AUD | 391.5K AUD | ||
| Other current liabilities | 30.6K AUD | 45.3K AUD | ||
| Total Current Liabilities | 1.8M AUD | 2.0M AUD | ||
| Employee benefit obligations | 42.2K AUD | 22.7K AUD | ||
| Other non-current liabilities | 158.9K AUD | 71.9K AUD | ||
| Total Non-Current Liabilities | 201.1K AUD | 94.6K AUD | ||
| TOTAL LIABILITIES | 2.0M AUD | 2.1M AUD | 2.8M AUD | |
| NET ASSETS | 11.2M AUD | 8.1M AUD | ||
| Issued capital | 95.7M AUD | 88.9M AUD | 88.5M AUD | 88.4M AUD |
| Reserves | 479.5K AUD | 1.6M AUD | ||
| Accumulated losses | -85.0M AUD | -82.4M AUD | ||
| TOTAL EQUITY | 11.2M AUD | 8.1M AUD | 12.7M AUD | 19.6M AUD |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.4
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Receipts from customers | 8.5M AUD | 7.6M AUD | 4.7M AUD |
| Payments to suppliers and employees | -13.2M AUD | -14.8M AUD | -12.9M AUD |
| Australian R&D tax incentive refund | 1.1M AUD | 768.4K AUD | 395.0K AUD |
| Grants received from government and non-government sources | 339.8K AUD | 274.7K AUD | 1.9M AUD |
| Net Cash Flows Used In Operating Activities | -3.3M AUD | -6.1M AUD | -5.9M AUD |
| Payments for purchases of plant and equipment | -4.8K AUD | -195 AUD | |
| Proceeds from maturity/(payments for) term deposit | 3.0M AUD | -3.0M AUD | |
| Interest received | 209.1K AUD | 135.9K AUD | 327.8K AUD |
| Net Cash Flows From/(Used In) Investing Activities | 3.2M AUD | -2.9M AUD | 327.6K AUD |
| Proceeds from issues of securities | 7.1M AUD | 396.8K AUD | 24.0K AUD |
| Payments for share buy-back | -121.8K AUD | ||
| Share issue transaction costs | -493.1K AUD | -124.1K AUD | |
| Principal elements of lease payments | -43.9K AUD | -65.7K AUD | -15.6K AUD |
| Interest and other costs of finance paid | -14.7K AUD | -7.3K AUD | -7.6K AUD |
| Net Cash Flows From Financing Activities | 6.5M AUD | 199.7K AUD | 829 AUD |
| Net Increase/(decrease) in cash and cash equivalents | 6.5M AUD | -8.8M AUD | -5.6M AUD |
| Effects of exchange rate changes on cash and cash equivalents | -268.8K AUD | 10.8K AUD | 49.3K AUD |
No quarter-by-quarter statement was filed.
What it owns
What Immuron Ltd reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Investments
Leadership
Who has led Immuron Ltd, and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
- Chief executive officerSteven George Lydeamore Apr 29, 2026 to now6
- ChairPaul Gerard Brennan May 4, 2026 to now7
- Chief financial officerAaron James Laurita Apr 29, 2026 to now8
Board members and other officers (5)
- Chief Scientific OfficerJerry Kanellos Apr 29, 2026 to now9
- Chief Commercial OfficerFlavio Palumbo May 14, 2026 to now10
- Board memberJeannette Anne Joughin Apr 29, 2026 to now11
- Board memberRavi Savarirayan Apr 29, 2026 to now12
- Board memberDaniel Jude Pollock May 14, 2026 to now13
Timeline
- Apr 29, 2026New chief executive Steven George Lydeamore becomes CEO6
Filings
204 filings to the SEC since October 2021: 6 annual reports, 8 insider forms, 190 other. The latest 20:
- Oct 13, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Sep 24, 202620-F ANNUAL REPORT EDGAR
- Sep 24, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Sep 22, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Sep 4, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Aug 28, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Aug 19, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Aug 13, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Jul 27, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Jul 21, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Jul 20, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Jul 16, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Jul 6, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Jun 29, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Jun 23, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- Jun 22, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- May 28, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
- May 14, 20263 EDGAR
- May 14, 20263 EDGAR
- May 8, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
The 204 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Citadel Advisors LLC | 43,123 | $45.7K | 0.0% | +29,319 |
| Rhumbline Advisers | 7,367 | $7.8K | 0.0% | No change |
| Bnp Paribas Financial Markets | 5,200 | $5.5K | 0.0% | +600 |
| Morgan Stanley | 1,700 | $1.8K | 0.0% | −28,874 |
| UBS Group AG | 363 | $385 | 0.0% | New |
| Hrt Financial LP | 20,584 | $21 | 0.0% | New |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How Immuron Ltd is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARImmuron Ltd1
- CIK0001660046
- Filer statusNon-accelerated filer not an emerging growth company; not a shell company3
- Incorporated inAustralia3
- Fiscal year endsJune 301
- Industry code (SIC)2834 Pharmaceutical Preparations1
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
- Business address62 Lygon Street, Level 3, Carlton, Victoria, C3 30531
- Phone61 03 9824 52541
- Shares outstanding322,848,081 shares as of Jun 30, 20263
- AuditorGRANT THORNTON AUDIT PTY LTD, Melbourne, Victoria PCAOB ID 2233; no auditor attestation of internal control over financial reporting3
- On EDGAR sinceDec 21, 20161
- Filings421 in all: 6-K (322), CORRESP (20), 20-F (10), UPLOAD (10), 3 (8), F-1/A (8), 424B5 (6), FWP (5)1
All 25 form types
424B3 (4), EFFECT (4), 6-K/A (3), F-3 (3), SC 13G (3), SC 13G/A (3), 424B4 (2), 25-NSE (1), 8-A12B (1), CERTNAS (1), CT ORDER (1), F-1 (1), F-1MEF (1), NT 20-F (1), POS AM (1), RW (1), SC 13D (1)
- Latest filingsAnnual report (20-F) Sep 24, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| American Depositary Shares, each representing 40 Ordinary Shares | IMRN | The Nasdaq Stock Market LLC |
From the cover page of the 20-F filed Sep 24, 2026 (Section 12(b) of the Exchange Act).3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARImmuron Ltd filings on SEC EDGAR
- 2SEC EDGARImmuron Ltd filings on SEC EDGAR
- 3
- 4
- 5SEC EDGARImmuron Ltd 10-K for fiscal 2023
- 6
- 7SEC EDGARPaul Gerard Brennan, Chair
- 8
- 9
- 10
- 11SEC EDGARJeannette Anne Joughin, Board member
- 12SEC EDGARRavi Savarirayan, Board member
- 13SEC EDGARDaniel Jude Pollock, Board member